| Ashley Cochran, DO | |
|
12200 Ashford Dr, Yukon, OK 73099 | |
| (405) 283-9000 | |
| (405) 283-9025 |
| Full Name | Ashley Cochran |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 12200 Ashford Dr, Yukon, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326427691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5957 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integris Ambulatory Care Corporation | 2365408465 | 382 |
News Archive
About 10 percent of mothers experienced chronic, persistent depressive symptoms two years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated at more than $100 billion, according to a Georgia State University study.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
The Washington Post reports that some Republicans are urging House leaders to back higher tax rates for the wealthy in exchange for a deal to rein in spending on safety-net programs. Other news outlets report that AARP and other groups are warning lawmakers about the hazards of cutting benefits as part of a deficit reduction package.
› Verified 5 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
About 10 percent of mothers experienced chronic, persistent depressive symptoms two years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated at more than $100 billion, according to a Georgia State University study.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
The Washington Post reports that some Republicans are urging House leaders to back higher tax rates for the wealthy in exchange for a deal to rein in spending on safety-net programs. Other news outlets report that AARP and other groups are warning lawmakers about the hazards of cutting benefits as part of a deficit reduction package.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Cochran, DO 5300 N Independence Ave Ste 280, Oklahoma City, OK 73112-5555 Ph: (405) 283-9000 | Ashley Cochran, DO 12200 Ashford Dr, Yukon, OK 73099 Ph: (405) 283-9000 |
News Archive
About 10 percent of mothers experienced chronic, persistent depressive symptoms two years after Hurricane Katrina slammed into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated at more than $100 billion, according to a Georgia State University study.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
The Washington Post reports that some Republicans are urging House leaders to back higher tax rates for the wealthy in exchange for a deal to rein in spending on safety-net programs. Other news outlets report that AARP and other groups are warning lawmakers about the hazards of cutting benefits as part of a deficit reduction package.
› Verified 5 days ago
Kyle W Rickner, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11 Palm Ave, Yukon, OK 73099 Phone: 405-350-5140 | |
Billy H. Sipes, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 520 S Mustang Rd, Yukon, OK 73099 Phone: 405-936-5910 Fax: 405-577-2605 | |
James M Brown, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1491 Health Center Parkway, Yukon, OK 73099 Phone: 405-806-2200 Fax: 405-806-2207 | |
Dr. Lydia J Dennis, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 520 S Mustang Rd, Yukon, OK 73099 Phone: 405-936-5910 Fax: 405-577-2605 | |
Dr. Brian Emil Thatcher, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 Health Center Pkwy Ste 100, Yukon, OK 73099 Phone: 405-717-5400 Fax: 405-717-5467 | |
Dr. Shea Pelham Pielsticker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 Health Center Pkwy, Yukon, OK 73099 Phone: 405-717-6851 | |
William L Welden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 436 S Mustang Rd, Yukon, OK 73099 Phone: 405-324-4000 Fax: 405-577-2328 |